2101 ORAL Phase III study of ixabepilone plus capecitabine in patients with metastatic breast cancer (MBC) progressing after anthracyclines and taxanes: subgroup analysis of patients receiving ixabepilone in the first-line setting

✍ Scribed by J. Jassem; E. Thomas; H. Gomez; R.K. Li; H.C. Chung; L.E. Fein; V.F. Chan; R.A. Peck; P. Mukhopadhyay; H. Roché

• Book ID: 118625705
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 76 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70863-7